• Post-acute COVID-19 Syndrome (PACS)
  • Toxoplasma IgM
  • Valproic Acid, Total, Serum
  • Alanine Aminotransferase (ALT)
  • CSRP3 Gene Mutation Analysis
  • Muscle Actin, IHC
  • Carnitine, Total, Serum/Plasma
  • Gene Expression Profile for Cutaneous Melanoma, DermTech (DecisionDx®-SCC), Pigmented Lesion Assay (PLA), myPath® Melanoma
  • MPL (MPL Proto-oncogene, Thrombopoietin Receptor) Gene Mutation Analysis
  • MSK-IMPACT™, Solid Organ Gene Cancer Panel
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Alpha-L-Iduronidase (IDUA) Gene Mutation Analysis, Full Sequencing
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Alpha-L-Iduronidase (IDUA) Gene Mutation Analysis, Full Sequencing
Medical Test

Overview
Access to Alpha-L-Iduronidase (IDUA) Gene Mutation Analysis, Full Sequencing is restricted.